theory clinical_2_0
imports Main


begin

typedecl entity
typedecl event

consts
  SyntheticLethality :: "event ⇒ bool"
  CoOccurrence :: "event ⇒ bool"
  GeneticEvent :: "event ⇒ bool"
  CellDeath :: "event ⇒ bool"
  
  PARPInhibitors :: "event ⇒ bool"
  Cause :: "event ⇒ bool"
  Breaks :: "event ⇒ bool"
  ReplicationAssociated :: "event ⇒ bool"
  DoubleStrand :: "event ⇒ bool"
  Preventing :: "event ⇒ bool"
  Repair :: "event ⇒ bool"
  SingleStrand :: "event ⇒ bool"
  Relying :: "event ⇒ event ⇒ bool"
  Agent :: "event ⇒ event ⇒ bool"
  HomologousRecombination :: "event ⇒ bool"
  ErrorProne :: "event ⇒ bool"
  NonHomologousEndJoining :: "event ⇒ bool"
  DNA :: "event ⇒ bool"

(* Explanation 1: Synthetic lethality is when co-occurrence of multiple genetic events results in cell death *)
axiomatization where
  explanation_1: "∀e. SyntheticLethality e ⟶ CoOccurrence e ∧ GeneticEvent e ∧ CellDeath e"

(* Explanation 2: PARP inhibitors cause replication‐associated double strand breaks by preventing single strand break repair, relying on defective homologous recombination repair and error prone non-homologous end joining to repair DNA *)
axiomatization where
  explanation_2: "∀e1 e2 e3 e4. PARPInhibitors e1 ∧ Cause e1 ∧ Breaks e1 ∧ ReplicationAssociated e1 ∧ DoubleStrand e1 ∧ Preventing e1 ∧ Repair e1 ∧ SingleStrand e1 ∧ Relying e2 e1 ∧ Agent e2 e1 ∧ HomologousRecombination e3 ∧ ErrorProne e3 ∧ NonHomologousEndJoining e3 ∧ Repair e3 ∧ DNA e3"


theorem hypothesis:
 assumes asm: "Patient x ∧ BRCA2Loss y ∧ PARP1Inhibition z"
  (* Hypothesis: Patients with loss of BRCA2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA *)
 shows "∃x y z e1 e2. Patient x ∧ BRCA2Loss y ∧ PARP1Inhibition z ∧ SyntheticLethality e1 ∧ Cause e1 ∧ Agent e1 z ∧ Patient e1 x ∧ Rely e2 ∧ Agent e2 x ∧ Mechanism e2 ∧ Repair e2 ∧ Damage e2 ∧ DNA e2"
  sledgehammer
  oops

end
